Realm Therapeutics Publicly Files Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Ordinary Shares

Realm Therapeutics Publicly Files Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Ordinary Shares

MALVERN, Pa., May 23, 2018 /PRNewswire/ — Realm Therapeutics plc (AIM: RLM) (the Company or Realm), a clinical stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, today announces it publicly filed a registration statement with the United States Securities and